Discussion about this post

User's avatar
PowerLawInvesting's avatar

I tend to think on future out-of-the-world bluesky scenarios:

1) I'm curious on your thoughts for their goals in Silicon Photonics. If they really want to compete, it seems moving to 300mm and 22nm or below is necessary. Will they really pull the trigger?

2) Also curious on neuromorphic front, if it would be smart for them to acquire some memory IPs (like weebit or 4DS) to round out their analog portfolio?

3) If GaN-on-Si appears to be big down the road, how can they compete without 300mm?

4) What's the outlook on microfluidics? Are there any interesting applications in the field of biotech that might make this piece of business important?

Expand full comment
Critical Conditions's avatar

A beautifully written piece. But to me, from what I just read, XFAB looks like a no-growth company, a essentially a bond substitute, with risks higher than those of a bond.

Expand full comment
12 more comments...

No posts